Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $52 Price Target

Wedbush analyst Robert Driscoll has reiterated an 'Outperform' rating on IDEAYA Biosciences (NASDAQ: IDYA) and maintained a price target of $52 for the stock.